General Changes. If such regulatory changes apply generally to one or more Drug Products as well as to other products Produced by ▇▇▇▇▇▇ for itself or for third parties, then CLIENT shall pay a pro rata amount of the reasonable cost of such regulatory changes based upon the proportion of time that such facility is dedicated to the Production of Drug Products relative to the Production of such other products.
Appears in 2 contracts
Sources: Drug Product Development and Clinical Supply Agreement, Manufacturing and Clinical Supply Agreement (Auxilium Pharmaceuticals Inc)
General Changes. If such regulatory changes apply generally to one or more Drug Products as well as to other products Produced by ▇▇▇▇▇▇ for itself or for third parties, then CLIENT shall pay a pro rata amount of the reasonable cost of such regulatory changes based upon the proportion of time that such facility is dedicated to the Production of Drug Products relative to the Production of such other products. Article 9, CONFIDENTIALITY.
Appears in 1 contract
Sources: Manufacturing Agreement
General Changes. If such regulatory changes apply generally to one or more Drug Products as well as to other products Produced by ▇A▇▇▇▇▇ for itself or for third parties, then CLIENT shall pay a pro rata amount of the reasonable cost of such regulatory changes based upon the proportion of time that such facility is dedicated to the Production of Drug Products relative to the Production of such other products.
Appears in 1 contract
Sources: Drug Product Development and Clinical Supply Agreement (Bio-Path Holdings Inc)